
---
markmap:
  colorFreezeLevel: 6
---

## Telomere

-   **Structure**
    -   Repeat sequences (e.g., Human: TTAGGG)
    -   Single-stranded overhang (3')
    -   T-loop and D-loop formation (Shelterin complex)
-   **Function**
    -   Protect chromosome ends
    -   Prevent fusion/recombination
    -   Prevent DNA damage response (recognizing ends as breaks)
    -   Maintain genomic stability
    -   **Hayflick Limit:** Cellular senescence linked to shortening
-   **Telomere Shortening**
    -   With each cell division (End replication problem)
    -   Oxidative stress
    -   Inflammation
-   **Telomerase**
    -   **Enzyme:** Reverse Transcriptase (hTERT - catalytic subunit)
    -   **RNA Template:** hTR / TERC (Telomerase RNA Component)
    -   **Function:** Extends 3' overhang
    -   **Activity:** High in germ cells, stem cells, cancer cells. Low/Absent in somatic cells.
    -   **Regulation:** Complex (Transcriptional, Post-translational, Structure association)
-   **Clinical Significance**
    -   **Aging:** Telomere shortening linked to cellular senescence and age-related diseases
    -   **Cancer:** Telomerase reactivation allows indefinite proliferation
    -   **Telomeropathies (Short Telomere Syndromes)**
        -   Genetic disorders (TERT, TERC mutations common)
        -   Premature aging features
        -   Bone marrow failure (e.g., Aplastic Anemia)
        -   Pulmonary fibrosis
        -   Liver cirrhosis
        -   Immunodeficiency
        -   Nail dystrophy, oral leukoplakia, skin pigmentation (Dyskeratosis Congenita)
-   **Associated Factors**
    -   **Shelterin Complex:** Protects telomeres (TRF1, TRF2, RAP1, TIN2, TPP1, POT1)
    -   **ALT Pathway:** Alternative Lengthening of Telomeres (Recombination-based, in some cancers)
    -   **DNA Damage Response:** ATR pathway activated by unprotected telomeres
-   **INICET Buzzwords**
    -   TTAGGG Repeat
    -   Hayflick Limit
    -   Shelterin
    -   TRF1/TRF2
    -   POT1
    -   hTERT / TERC (hTR)
    -   Dyskeratosis Congenita
    -   Aplastic Anemia
    -   Pulmonary Fibrosis
    -   ALT pathway
    -   End replication problem
